Halo Leadership

Anissa Kalinowski, MBA, MSc

CEO, Cofounder

Daniel C. Maneval, PhD

Anissa Kalinowski, MBA, MSc

CSO (Consulting)

Sangita Ghosh, PhD

Anissa Kalinowski, MBA, MSc

Ramona Doyle, MD, MSc

Chief Technology Advisor

Ramona Doyle, MD, MSc

CMO (Consulting)

Rudy Paladini, PhD

Ramona Doyle, MD, MSc

Rudy Paladini, PhD

VP, Preclinical Development

Ray Liu, PhD

Ramona Doyle, MD, MSc

Rudy Paladini, PhD

Chief Toxicology Advisor

Scientific Advisors

Paul Bollyky, MD, PhD

Vinicio de Jesus Perez, MD

Paul Bollyky, MD, PhD

Scientific Cofounder, Stanford University Professor

Roham Zamanian, MD

Vinicio de Jesus Perez, MD

Paul Bollyky, MD, PhD

Pulmonary and Critical Care Medicine, Stanford University

Vinicio de Jesus Perez, MD

Pulmonary and Critical Care Medicine, Stanford University

Nadine Nagy, PhD

Vinicio de Jesus Perez, MD

4-MU and Stanford Scientist,

Scientific Cofounder

Harry Karmouty-Quintana, PhD

Preclinical Development

(Pulmonary Hypertension)

Adam Frymoyer, MD

Harry Karmouty-Quintana, PhD

PK/PD and Clinical Development

Julio Medina, PhD

Harry Karmouty-Quintana, PhD

Julio Medina, PhD

Medicinal Chemistry

Business Advisors and Operations

Andy Wardle, MD, MBA

Cofounder, Business Development Advisor

Larry Frye, MBA

Andy Wardle, MD, MBA

Catalyst, Stanford University

Thomas Huot, PhD

Andy Wardle, MD, MBA

Jenny Chaplin, BSc

Business and Corporate Development

Jenny Chaplin, BSc

Sylvie Dobrota Lai, MSc

Jenny Chaplin, BSc

Strategic Operations and Project Management

Sylvie Dobrota Lai, MSc

Associate Director, Clinical Development

Meg Snowden, JD

Sylvie Dobrota Lai, MSc

IP and Legal